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Abstract
The intestinal barrier is constantly exposed to potentially harmful environmen-
tal factors including food components and bacterial endotoxins. When the intestinal
barrier function and immune homeostasis are compromised, inflammatory condi-
tions may be developed and impact overall health. Evidence from experimental
animal and cell-culture studies suggests that exposure of intestinal mucosa to
proanthocyanidin-rich plant products may contribute to maintain the barrier func-
tion and to ameliorate the inflammation present in prevalent pathologies such as
diet-induced obesity and inflammatory bowel disease. In this review, we aim to
update the current knowledge on the bioactivity of PACs in experimental models of
altered intestinal permeability and in humans, emphasizing the beneficial effects
of grape-seed proanthocyanidin extracts in intestinal health and giving insights into
the subjacent biochemical and molecular mechanism.
Keywords: gut, permeability, inflammation, metabolic endotoxemia, obesity, IBD,
flavonoid, flavan-3-ol, condensed tannin, procyanidin
1. Introduction
The primary function of the intestinal tract is to digest food components and
absorb nutrients and water from the lumen to the systemic circulation. The intes-
tine is also a physical barrier that is in contact with the environment. As a result, the
intestinal epithelium is constantly exposed to potentially pathogenic microorgan-
isms, toxins, and harmful components of the diet. When there are disturbances in
the barrier function and mucosal immune homeostasis, the influx of intestine
luminal content triggers barrier dysfunction and an exaggerated mucosal immune
response [1]. Ultimately, chronic exposition to these detrimental environmental
stimuli may lead to the development of local and systemic inflammatory conditions
[2, 3] that contribute to barrier dysfunction.
Natural products have been recognized as a source of therapeutic agents for
many years [4]. Some plant-derived phenolic compounds show promising
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anti-inflammatory effects and have been associated with the prevention of certain
chronic diseases [5]. Proanthocyanidins (PACs), also known as condensed tannins,
are oligo- and polymeric end products of the flavonoid biosynthesis pathway in
plants [6]. There has been extensive laboratory research into the effects of both
pure PAC molecules and PAC-rich extracts on overall health. These phytochemicals
show a wide range of physiological activities [7], including anti-inflammatory and
barrier-protective effects in the intestine [8–10], which may be interesting in the
context of diet-induced obesity and inflammatory bowel disease (IBD).
We have reported previously that grape-seed PACs and other flavonoids have
beneficial effects on inflammation [11–13] and protect the intestine against alter-
ations associated with diet-induced obesity in rats [8, 9, 14, 15]. In addition,
research conducted during the last decade with cell culture and animal models has
made significant progress in determining the underlying mechanism of the health-
promoting properties of PACs in the gastrointestinal tract and peripheral tissues.
2. Altered networks in intestinal dysfunction: barrier integrity
and inflammatory response
The intestinal epithelium is a single cell-layer responsible for separating under-
lying mucosal tissues from the environment and is the largest exposed surface area
in the body [16]. As there is a prolific commensal microbial community in the
intestinal lumen (intestinal microbiota), epithelial integrity plays a pivotal role in
maintaining overall health [16, 17]. The intestinal epithelium is integrated by sev-
eral cell types with specialized functions. The enterocytes are responsible for the
absorptive function and constitute the most abundant epithelial cell lineage. The
goblet cells are implicated in the synthesis of secretory mucin glycoproteins that
form the mucus layer [18]. Other cellular types integrating the epithelium,
microfold (M) [19], Paneth and enteroendocrine cells are specialized in antigen
sampling and presentation to dendritic cells, synthesis of antimicrobial peptides,
and secretion of hormones, respectively.
The first strategy the host tissue has to maintain its homeostatic relationship
with the intestinal microbiota is to minimize the physical interaction with microor-
ganisms, thus limiting microbial translocation and physiological inflammation
[20, 21]. The thick mucus layer secreted by goblet cells represents a primary defense
line against environmental insults [18]. In addition, the enterocytes are joined
together forming an intricately and well-regulated barrier sustained by intercellular
junctions linked to the cell cytoskeleton, such as tight junctions (TJs), desmosomes,
and adherent junctions. TJs partially seal the paracellular space and prevent passive
transport of large molecules, including microbial components and other potentially
harmful agents [1, 22].
The paracellular and transcellular pathways are the two major pathways medi-
ating transmembrane transfer of intestinal bacterial substances. Both mechanisms
may be involved in intestinal mucosal barrier damage and bacterial translocation.
The paracellular pathway is integrated by tight junctions (TJs), consisting of
zonulin/zonula occludens (ZO)-1, occludin, claudins, junction adhesion molecules
(JAMs), and actin-myosin cytoskeletal proteins. Previous studies have shown that
inflammatory cytokines and bacterial antigens can affect the expression level and
assembly of these elements, thereby exerting an influence on TJ functions [23].
Immune cells, including neutrophils, dendritic cells, and monocytes, have also been
directly implicated in inducing disturbances in TJ barrier function. It has been
postulated that pro-inflammatory cytokine-induced opening of the intestinal TJ
barrier is an important mechanism contributing to the TJ barrier defects present in
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various inflammatory conditions of the gut [24]. Previous studies [25–28] have
shown that myosin light chain kinase (MLCK) plays a central role in the regulation
of intestinal TJ permeability. The activation of MLCK catalyzes the phosphorylation
of myosin light chain (MLC), inducing contraction of the peri-junctional actin-
myosin filaments and the opening of the TJ barrier. In contrast, inhibition of MLCK
activation prevents this effect [27]. It has been suggested that the cytokine-
mediated barrier dysfunction could be mediated by an increase in Nuclear
Factor (NF)-kB, which, in turn, activates MLCK gene and protein expression [29]
(Figure 1).
Once intestinal bacteria and endotoxins enter the portal vein and/or lymphatic
system, they can reach other tissues and organs, leading to a cascade response
modulated by inflammatory mediators. This situation can induce a systemic
inflammatory response, which further damages the function of the intestinal barrier
[30]. The endotoxin-signaling pathway includes the binding of LPS to LPS-binding
protein (LBP) and its subsequent transfer to the CD14 receptor. LBP-bound LPS
initiates inflammation via TLRs associated with membrane-anchored CD14 [31].
TLRs are a family of pattern-recognition receptors that play a key role in the innate
immune system. Among all, the TLR4 is expressed at high levels in the intestinal
tract, and given that LPS is its specific ligand, TLR4 could be considered the first
barrier for recognition of bacterial presence in the gastrointestinal tract. NF-kB is
the final effector transcription factor of the TLR4 signaling pathway. It promotes
the development of many intestinal diseases and also plays a pivotal role in the
translation and transcription of inflammatory mediators [30].
In mammals, the NF-kB family comprises five proteins, including p65 (RelA),
RelB, c-Rel, p105/p50 (NF-kB1), and p100/p52 (NF-kB2), which associate with
each other to form transcriptionally distinct homo- and heterodimeric complexes;
the p65:p50 heterodimer is the most abundant and the most relevant for inflamma-
tion [32]. In resting cells, the p65:p50 NF-kB heterodimer is sequestered in the
cytoplasm by binding to its inhibitory protein, IkappaB (IkB). In response to an
inflammatory stimulus, such as LPS, the classical NF-kB activation pathway leads to
the activation of the IkB kinase (IkkB), a member of the IKK complex, triggering
IkB-a phosphorylation (pIkB-a). Then, pIkB-a is recognized by the ubiquitin ligase
machinery, resulting in its polyubiquitination and subsequent proteasomal
Figure 1.
Protective properties of PACs in the intestinal barrier function. (A) Chronic exposition to detrimental
environmental stimuli may lead to dysbiosis, breakdown of the intestinal barrier, influx of bacterial endotoxins
and mucosal inflammation. (B) PACs ameliorate loss of barrier function blocking the activation of MLCK
mediated by NF-κB and MAPK signaling. See text for details.
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degradation. After pIkB-a degradation, the p65:p50 heterodimers are able to
translocate to the nucleus, where they bind to the kB motif found in the promoter
or enhancer regions of numerous pro-inflammatory genes to induce their
expression [33].
NF-kB target genes include cytokines (e.g., tumor necrosis factor (TNF)-α and
interleukins), adhesion molecules, acute phase proteins, and inducible enzymes
(inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2)), among
others [11]. All of these genes contain verified NF-kB binding sites in their
sequences, providing strong experimental evidence for their direct control by
NF-kB [34]. Among all of these genes, the expression of iNOS and COX2 has been
widely studied in relation to intestinal inflammation. In this regard, sustained high
nitric oxide (NO) production by iNOS plays a role in the pathology of chronic
inflammatory bowel disease [35, 36]. During the last decade, it has become increas-
ingly clear that NO overproduction by iNOS is deleterious to intestinal function
[37], thus contributing significantly to gastrointestinal immunopathology.
Cyclooxygenases are enzymes that are responsible for the metabolism of
arachidonic acid, converting it into prostaglandins. These products influence a wide
variety of biological processes, ranging from homeostasis to inflammation [38].
There are two cyclooxygenase isoforms: the constitutive COX1 isoform and the
inducible COX2 isoform [38, 39]. As a result of COX2 induction, prostaglandin E2
levels increase at the site of inflammation and can also be detected systemically.
Multiple environmental factors have been identified as potential triggers of
intestinal inflammatory conditions, including Western dietary habits [40]. It has
been described that saturated fats play a direct role in inflammatory signaling.
Saturated fatty acids (SFA) such as lauric (C12:0) and palmitic (C16:0) directly
induce NF-κB activation, acting as non-microbial TLR2 and TLR4 agonists in mac-
rophages [41]. Data suggest that activation of TLRs by SFA is mediated by TLR
dimerization and recruitment into lipid rafts [42]. We have reported mild intestinal
inflammation and increased permeability in rats feeding on a cafeteria diet
consisting of high-saturated fat/high-refined sugar food products [43]. This
enhanced permeability has been shown to favor bacterial LPS and other potentially
pro-inflammatory molecules entering the systemic circulation, which is known as
metabolic endotoxemia [15].
Taken together, these data suggest that HF diet-induced changes in the intestinal
microbiota could be responsible for metabolic endotoxemia and for the onset of the
corresponding diseases. The causative link between changes in intestinal bacteria
populations, endotoxemia, and metabolic disease needs further assessment [44],
but the mechanisms likely include altered epithelial permeability, translocation of
bacterial products, and upregulation of pro-inflammatory cytokines and hormones
produced by gut endocrine cells, mechanisms which might be modulated by PACs.
3. PACs: chemical structure, occurrence, and intake
PACs consist of flavan-3-ol subunits with a degree of polymerization (DP) equal
to or greater than 2, mainly linked by (4! 8) or (4! 6) carbon-carbon bonds (B-
type PACs) [45]. In some botanical sources an additional (2! 7) ether-linkage also
occurs (A-type PACs) [46] (Figure 2). Depending on the type of monomers, PACs
can be classified into procyanidins, prodelphinidins, and propelargonidins. The
most abundant group, procyanidins, consists exclusively of (+)- catechin and ()-
epicatechin monomers [47]. Prodelphinidins and propelargonidins are composed of
()- gallocatechin/()- epigallocatechin and (+)- afzelechin/()- epiafzelechin
monomers, respectively [45], and have a more limited distribution
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Dietary assessment studies have shown that PACs, especially procyanidins are
among the most abundant polyphenols in the human diet [6], as they are present in
a variety of botanical sources and plant food products such as tea, fruits, nuts, cacao
products, legumes, and cereal grains [1, 2]. However, PAC intake varies widely
between geographical regions and cultures and is greatly dependent on eating
habits, lifestyle behaviors, and socioeconomic status [48]. The daily PAC (dimers
to polymers) intakes in adult populations from Korea, the U.S., Mexico, and EU
were estimated as 71 [49], 73 [48], 103 [50], and 123–180 mg [51, 52], respectively,
but intakes up to 230 mg d1 have been reported in some regions of Spain and
Norway [53]
4. The fate of PACs after ingestion
Flavan-3-ols are remarkably stable during gastric transit in humans [54]. Mono-
mers such as (+)- catechin and ()- epicatechin are readily absorbed in the upper
sections of the small intestine [55, 56], recognized as xenobiotics and then subjected
to an extensive phase II metabolism that generates glucuronidated, sulfated, and
methylated conjugates [57]. Flavan-3-ol monomers and their conjugated metabo-
lites reach peak plasma concentration 1–4 h after flavan-3-ol-rich food consumption
[58–60]. Studies conducted in cultivated epithelial monolayers [61–63], rats
[64, 65], and humans [60, 66] indicate that PAC absorption is conversely more
Figure 2.
Chemical structures of PACs. Flavan-3-ol monomers differ based on the hydroxylation pattern and their cis- or
trans-configuration. Dimers A1/A2 and B1/B2 are shown as example of A- and B-type PACs, respectively.
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limited and is highly dependent on DP, and that the permeation of larger oligomers
(DP > 5) and polymers is negligible. No PAC transporter has been identified in the
enterocyte membrane in the small intestine. Thus, dimers to tetramers are passively
transported across the intestinal epithelium essentially by paracellular diffusion.
Although transcellular passive diffusion is not likely to occur due to the hydrophilic
nature of PACs conferred by the multiple hydroxyl groups, uptake might be possi-
ble by endocytic mechanisms [62].
In humans, a study assessed the contribution of the ingested cocoa flavan-3-ols
and procyanidins to the systemic pool, and found that the plasma ()- epicatechin
came from the orally administered cocoa ()- epicatechin and not from their
oligomers or polymers [67]. This is in agreement with the evidence obtained with
rats that suggests that PACs from different sources do not depolymerize to mono-
mers after ingestion [68, 69]. Stalmach et al. [56] conducted a study with
ileostomized patients who were administered green tea, and found 70% of the
ingested flavan-3-ol in the ileal fluid after 24 h. Altogether, these findings suggest
that substantial amounts of ingested flavan-3-ol monomers and PACs remain
unabsorbed in the small intestine and reach the colon. There, they are efficiently
transformed by the colonic microbiota into low molecular weight phenolic com-
pounds that can be absorbed by colonocytes [57].
In vitro fermentation of purified procyanidin dimers with human fecal
microbiota has shown to produce mainly 2-(30,40-dihydroxyphenyl) acetic acid and
5-(30,40-dihydroxyphenyl)-γ-valerolactone [70]. In agreement with this, a random-
ized cross-over study in healthy humans found that a great portion of the ingested
()- epicatechin and procyanidin B1 was metabolized by the colonic microbiota to
produce phenyl-γ-valerolactones as the major microbial metabolites [60]. In this
study, microbial degradation of larger procyanidins was substantially lower, possi-
bly to the inhibition of digesting enzymes or to the antibacterial properties
exhibited by these compounds. Other human studies analyzing the bioavailability of
flavan-3-ols, reported high levels of phenyl-γ-valerolactones in the circulation and
urinary excretion after ingestion of a red grape pomace drink [71] and apple juice
[72]. In the colonocytes and hepatocytes, these microbial products undergo further
metabolism by phase II enzymes to produce conjugated derivatives. Margalef et al.
[73] analyzed the tissue distribution of metabolites derived from a grape-seed
proanthocyanidin extract (GSPE) 2 h after ingestion by rats. These authors detected
a few microbial metabolites (methyl conjugated phenols) at low concentrations in
the colon tissue, while most phase II metabolites (glucuronidated and methyl-
glucuronidated forms) were found in the kidneys and liver. In humans, the major
contributors to the excretion of phenyl-γ-valerolactones after ingestion of a red
grape pomace drink, are sulfated and glucuronidated conjugates of 5-(30,40-
dihydroxyphenyl)-γ-valerolactone [71].
5. In vitro, in vivo and ex vivo studies on the benefits of PACs
for intestinal dysfunction
During the last decade, the beneficial properties of PACs for intestinal function
have been reported in several studies performed with cell-culture models and
experimental animals (Tables 1 and 2). This experimental data indicate that PACs
contribute to maintaining the intestinal barrier and improving mucosal inflamma-
tion induced by environmental insults. However, there are few studies on the
effect of PACs on human intestinal health, although epidemiological
studies connect PAC-rich food consumption with a lower risk of colorectal
cancer [88].
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In vitro models of inflammation have been fundamental in the comprehension
of cellular mechanisms driving physiological effects of bioactive molecules. Studies
on intestinal dysfunction have employed human colon carcinoma cell lines, being
Caco-2 the most well-established and widely used model of the human intestine
barrier ([89] and Table 1). Mucus producer [79], macrophages [90], and B cell lines
[91] have been employed in co-culture systems to explore the interaction between
cell populations. Although there is a strong trend in the industry toward replacing
animal experiments with human cell-culture based models [92, 93], there are no
in vitro models of the human intestine that replicate the complex interplay between
cell types and the regulation of the barrier function by the mucosal innate and
adaptive immunity. Therefore, most physiologically relevant data on intestinal
dysfunction comes from the animal model. Most in vivo studies testing the effect of
PAC supplementation on intestinal health have been performed in diet-induced
obesity models and chemical-induced colitis models. The first resemble intestinal
alterations seen in humans with metabolic syndrome [43]. The latter closely mimic
histopathological features of human colitis and are frequently used to study the
pathophysiology of IBD and the effectiveness of novel therapeutic drugs [94].
Notably, PAC-rich grape-seed extracts (GSPE) are among the most studied botan-
ical extracts, mainly by in vivo approaches in rodents (Table 2).
5.1 In vitro studies of barrier integrity
The data available on the interaction between PACs and permeability and
inflammation markers in cell models of intestinal dysfunction are summarized in
Table 1. Caco-2-based models have shown to be responsive to pro-inflammatory
stimulation, producing a wide range of inflammatory mediators and increasing the
paracellular permeability. Pro-inflammatory agents such as LPS, phorbol 12-
myristate 13-acetate (PMA), and cytokines (TNF-α and IL-1β) have been used in
multiple studies testing the effect of PAC molecules and PAC-rich botanical extracts
on Caco-2 cells [10, 74, 77, 78]. Stimulated-Caco-2 cell monolayers incubated with
PACs generally show a reduction in gene expression and secretion of TNFα, IL-6,
and IL-8 [10, 74, 75, 77], which is often linked to the downregulation of NF-κB
signaling at different levels [10, 76, 77]. An increased expression of antioxidant
enzymes, such as glutathione peroxidase (GPx), superoxidase dismutase (SOD),
and hemeoxygenase 1 (HO-1), has also been reported [10].
When permeable support systems such as transwell or Ussing chamber (UCh)
are used, alterations in barrier integrity and paracellular permeability of epithelial
cell monolayers are evaluated by transepithelial electrical resistance (TEER), an
electrophysiological parameter that measures ion conductance across the mono-
layer, and by the transepithelial transport of molecular markers such as Lucifer
yellow (LY) and fluorescently labeled dextrans (FD) [95, 96]. Some in vitro studies
have associated PACs with increased TEER and decreased transport of permeability
markers in the context of barrier dysfunction [77, 78, 80]. The expression levels of
TJ proteins (claudins, occludins, and ZOs) often correlate, but not always [79], with
intestinal permeability and are also considered markers of epithelial integrity. Bitzer
et al. [78] found that the dextran sodium sulfate (DSS)-induced loss of barrier
function in Caco-2 cells was significantly inhibited by polymeric PACs of cocoa but
not by oligomers. Moreover, a higher barrier-protective activity was determined in
PACs with DP ≥ 7, which were able to reduce the detrimental effect of DSS in a
dose-dependent fashion [78]. Effectiveness of procyanidin B2 ameliorating dextran
sodium sulfate (DSS)-induced permeability alterations was examined using a Caco-
2/HT29-MTX co-culture model [79]. Although procyanidin B2-incubated cells
showed increased levels of the TJ proteins claudin-7, occludin, and ZO-1, these
10
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changes did not reduce TEER loss. Altogether, these results suggest that the ability
of PACs to strengthen the intestinal barrier integrity depends on the degree of
polymerization (DP).
5.2 In vivo studies of diet-induced intestinal permeability
The cafeteria (CAF) diet is a self-selected high-saturated fat/high-refined sugar
diet that stimulates hyperphagia and a rapid weight gain in experimental animals
[97, 98]. In this feeding regime, highly palatable and energy dense foods commer-
cially available, such as muffins, biscuits, bacon, sausages, and sugared milk, are
offered ad libitum [15, 99]. A long-term CAF diet (62% carbohydrate (mostly
sugar), 23% lipid, and 13% protein) has negative effects on intestinal function in
rodents, increasing intestinal permeability, and inducing mucosal inflammation
[43]. We have described the beneficial effects of administering GSPE against the
intestinal dysfunction induced by a long-term CAF diet (17–18 weeks) in Wistar
rats [8, 14, 15]. The composition of the GSPE used in these studies has been
analyzed in detail [100]. Both nutritional (5–50 mg kg1 [14]) and pharmacological
(100–500 mg kg1 [8, 15]) doses of GSPE administered orally as a preventive [8] or
counteractive treatment [14, 15], tended to reduce intestinal inflammatory markers
such as TNF-α release or myeloperoxidase (MPO) activity (an indicator of neutro-
phil infiltration in tissues). The reduction of plasma ovalbumin (OVA), an in vivo
marker of intestinal permeability, was supported by (1) the increase in TEER in
small and large intestine segments. This parameter is determined ex vivo by UCh-
based protocols [8, 15]; and (2) by the upregulation of TJ proteins such as ZO-1 [14]
and claudin-1 [8, 15]. Notably, the protective effect of GSPE in the intestinal barrier
function was linked to the amelioration of metabolic endotoxemia (reduction of
plasma LPS) and systemic inflammation (reduction of plasma TNF-α) in obese rats
[15, 101]. Other authors have also reported the upregulation of ZO-1 and claudin-1
TJ proteins in high-fat fed rats supplemented with other PAC-rich extracts [81].
5.3 In vivo studies of chemical-induced intestinal dysfunction
Chemical agents administered orally to induce colitis in rodents include
trinitrobenzene sulfonic acid (TNBS) and DSS. These agents erode the colonic
mucosal lining and produce the loss of the intestinal barrier function and colonic
inflammation. In these models, the severity of outcomes depends on the dose of the
chemical agent and the frequency of administration. Li et al. [102] found that
intragastric administration of GSPE in rats at pharmacological doses (100–
400 mg kg1 d1) prior to TNBS-induced recurrent colitis, reduced weight loss, and
attenuated macro- and microscopic tissue damage scores in the colon. This protec-
tive effect was accompanied by a reduction in oxidative stress (malondialdehyde;
MDA), inflammation (IL-1β), and neutrophil infiltration (MPO activity) in colonic
tissues. Remarkably, the beneficial effects of low to high doses of GSPE were
comparable to those of sulfasalazine (200 mg kg1 d1), a potent inhibitor of NF-
κB. Subsequent studies carried out by these authors with the same model, con-
firmed the role of the GSPE down-regulating NF-κB response [83, 84]. A preventive
effect of procyanidin B2 was also evidenced in a mouse model of DSS-induced
colitis [85]. Administration of procyanidin B2 (10–40 mg kg1 d1) attenuated the
severity of tissue damage in the colon and reduced the levels of matrix
metalloproteinase-9 (MMP-9), a marker of macrophage infiltration. In addition,
inhibition of the NF-κB signaling and of NLRP3 inflammasome activation was
observed, with a concomitant reduction in the gene expression of pro-inflammatory
cytokines. Overall, the benefits of procyanidin B2 administration, especially at the
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highest dosage (40mg kg1), were comparable to those of mesalazine (200
mg kg1), a COX inhibitor. The authors suggest that these effects were largely due
to the reduction in activated macrophages infiltrating colonic tissues, probably
driven by ROS clearance.
5.4 Other in vivo studies with animal models
The IL-10 deficient mouse is a classic knockout model that develops spontaneous
colitis under pathogen-free conditions. Some authors have explored the influence of
GSPE in this model, supplementing colitic animals with 0.1–1 g 100 g1 of dry feed
weight for 12–16 days [86, 87]. These studies evidenced a reduction of multiple
inflammatory markers in the jejunum and colon, such as TNF-α, IL-1β, IL-6, and
IFN-γ gene expressions, as well as MPO activity. This anti-inflammatory effect was
associated with the inhibition of the NF-κB signaling. Interestingly, GSPE supple-
mentation also increased the density of goblet cells in the jejunum of treated ani-
mals, suggesting that there is an alternative mechanism by which inflammation is
attenuated.
Cardoso et al. [13] recently tested both dietary (75 mg kg1) and pharmacolog-
ical doses of GSPE (375 mg kg1) in a rat model of mild intestinal dysfunction
induced by intraperitoneal injection of LPS. GSPE was administered daily by oral
gavage for 15 days prior to LPS-induced intestinal dysfunction. LPS enhanced
intestinal permeability and induced both oxidative stress and inflammation. GSPE-
treated animals reduced OVA permeation to the circulation, MPO activity and
COX-2 in the small intestine tissues, and reactive oxygen species (ROS) levels in the
colon. Furthermore, a gene expression analysis with a low-density microarray tech-
nique revealed that unlike the dietary dose of GSPE, the pharmacological dose had a
striking effect on the LPS-gene expression profile, showing a strong modulation of
multiple genes associated with chemokines and ILs, including upregulation of the
anti-inflammatory cytokine IL-13.
5.5 Human ex vivo studies
Although the use of animal models is the predominate approximation at pre-
clinical stages for testing novel therapies in intestinal permeability, there is a strong
trend in the industry towards replacing animal experiments with human cell-
culture based models [92, 93]. Nevertheless, advantages related to the usefulness of
in vitro models for screening of bioactives and exploring action mechanisms, are
offset by limitations regarding the mimicking of the in vivo situation and transla-
tion to the human [103]. Thus, some human ex vivo models have been proposed to
test immunomodulatory properties of drug candidates in intestinal explants from
IBD patients [104, 105]. Intestinal function can also be studied with UCh-based
protocols. The UCh system consists of two halves with an opening between them,
where mucosal tissue is adapted, thus isolating the apical and basolateral sides of the
tissue. This technique has been applied for studying drug absorption [106] and
secretion of enterohormones [107] in human endoscopic biopsies. An advantage of
UCh models over explant-based models is that UCh models make it possible to
measure the electrophysiological parameters, including TEER [106]. All these set-
ups permit analyzing the cytokine profiling of intestinal explants or biopsies
retaining their in situ conditioning in a polarized fashion [105, 108]. We have
employed the UCh to determine TEER and cytokine release (TNF-α) in intestinal
tissues from cafeteria diet-induced obese rats treated with GSPE [8, 15]. It could
also be useful for testing the effect of bioactives on dysfunctional human intestine.
12
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A feature of ex vivo models is that screening of drug effects does not compromise
the patients by exposing them to unknown outcomes.
5.6 Clinical trials
Translation of doses of PAC-rich extracts used in rodent models of intestinal
dysfunction to human equivalent doses (HED) indicates that pharmacological doses
(up to 5 g d1 for a 60 kg person) could be required to achieve beneficial effects in
clinical trials [14, 15]. Thus, the first uncertainty involved in assessing the use of
PACs as therapy agents in humans, is safety. Grape seed and skin
proanthocyanidin-rich extracts have been subjected to toxicological tests in rats to
determine their safety for use in functional foods [109–111]. In these studies, the
median lethal dose (LD50) was found to be greater than 5000 mg kg1 bw (HED of
≈50 g) when administered once by oral gavage, and 1400–2000 mg kg1 d1 (HED
of ≈14–20 g d1) was found to be the no-observed-adverse-effect level (NOAEL)
for systemic toxicity in sub-chronic administration. A recent study evaluated the
safety and tolerability of GSPE intake (up to 2.5 g d1) in a small number of healthy
adults for a 4-week period and found a good tolerability without adverse effects on
hematological or biochemical parameters [47].
To date, there are few clinical studies that evaluate the influence of PACs on
intestinal inflammatory conditions. A clinical study revealed that the postprandial
increase of plasma LPS associated with the intake of a high-fat meal was signifi-
cantly reduced in obese subjects who consumed 1 g of GSPE [112]. As translocation
of LPS to the circulation is considered an indicator of intestinal permeability and a
critical factor in the appearance of systemic low-grade inflammation in patients
with metabolic syndrome [113], reduction of postprandial endotoxemia could be
particularly interesting from a therapeutic perspective. Large double-blind clinical
studies need to be conducted to provide more information on PAC clinical efficacy
in intestinal dysfunction so that these phytochemicals can be used therapeutically to
improve intestinal health in obese and IBD individuals.
6. Biochemical and molecular mechanisms underlying the barrier-
protective and anti-inflammatory properties of PAC in the intestine
PACs were often considered to be nutritionally undesirable due to their ability to
form complexes with macronutrients and reduce the activity of virtually any
enzyme implicated in digestion [114, 115]. Nevertheless, based on the anti-
cancerous, anti-mutagenic, and anti-microbial activities these phytochemicals
elicited in laboratory experiments, a role in the modulation of the metabolism and
immune system was suggested [115]. The ability of PACs to form cross-links with
biomolecules can be attributed to the hydroxyl groups and aromatic rings in their
structure that can establish hydrogen bonds and hydrophobic interactions [116].
PACs have a significant affinity for proline-rich proteins and peptides [117]. In
general, binding to proteins seems to increase with the DP as larger PAC molecules
have more potential binding sites for the associations with proline residues [117].
The interaction results in effects determined by the biological function of the target
protein. Thus, PACs not only alter enzymatic activity, but they may also prevent
ligand-receptor interactions and the binding of transcription factors to their specific
sites in DNA. In addition, some PAC molecules can be adsorbed non-specifically
onto biomembrane surfaces [118], affecting their physical characteristics, such as
fluidity and density, and potentially altering membrane-dependent processes,
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including protein receptor activity [119]. Altogether, these effects lead ultimately to
the alteration of cell signaling pathways and the modulation of gene expression.
6.1 Modulation of TJ integrity
The precise mechanisms underlying the improvement in intestine paracellular
permeability due to PACs in inflammation are not yet completely elucidated; how-
ever, it is known that they lead ultimately to the upregulation (e.g., ZO-1 and
claudin-1 [8, 13]) or downregulation (e.g., claudin-2 [86]) of TJ protein expression.
Loss of TJ integrity in the pro-inflammatory state is mediated by the NF-κB signal-
ing pathway and by the activation of protein kinases MAPKs, PI3Ks, AMPK, and
MLCK [120]. MLCK is particularly crucial in actomyosin-based cytoskeletal func-
tions and multiple studies highlight its important role in intestinal TJ remodeling
[121, 122]. PACs reduce the production of pro-inflammatory mediators (e.g., TNF-
α) and reactive oxygen species (i.e., iNOS activity) associated with enhancing
intestinal permeability by antagonizing the NF-κB signaling pathway. In addition,
PACs are potent inhibitors of kinases including MLCK [120, 123]. Contreras et al.
[124] also suggested that there is an upstream novel mechanism associated with
flavan-3-ols that leads to the prevention of TNF-α-induced intestinal permeability.
In this study, TNF-α-stimulated Caco-2 monolayers incubated with ()-
epicatechin showed a reduction of NOX activity, an enzyme that also facilitates
activation of TNF-α signaling. This effect was directly associated with the inhibition
of ERK1/2 MAPK activity of IκB phosphorylation and of MLCK activation.
6.2 Interaction with bacterial endotoxins
Delehanty et al. [125] demonstrated that naturally occurring A- and B-type
cranberry PACs were able to bind the lipid A moiety of LPS, exhibiting an affinity
similar to that of polymyxin B, a potent LPS-binding molecule. In this study, PACs
efficiently blocked endocytosis of bacterial LPS in a dose-dependent manner in
HEK 293 (human embryonic kidney cells) that expressed receptors TLR4/MD-2
and CD14, thus preventing the induction of the NF-κB signaling pathway without
any interaction with cellular components. However, other authors reported that
PACs isolated from cocoa beans did not abrogate the binding of LPS to TLR4 in
cultivated human dendritic cells [126]. PAC-LPS binding has been linked to the
reduction of the post prandial increase in blood LPS associated with the ingestion of
a high-fat meal in obese subjects ingesting an oral dose of GSPE [112].
7. PACs modulation of intestinal microbiota
Diet plays an important role in the composition of intestine microbiota, pro-
moting or inhibiting growth of microorganisms [127]. Alterations in the composi-
tion and metabolism of the intestinal microbiota (dysbiosis) have also been
associated with the consumption of high-saturated fat diets in rodents and humans
[128, 129]. In fact, metagenomic analysis of the intestinal microbiome in Western
populations has shown a reduction not only of microbial diversity, but also of
functional potential [130]. Dysbiosis is linked to obesity-associated intestinal
inflammation, although the “egg or hen” question related to the cause-effect rela-
tionship is not answered yet [131]. High-fat intake in rodents often decreases overall
diversity of microbiota and the abundance of Bacteroidetes, and increases the
relative abundance of Firmicutes [132, 133]. Several human studies have described
similar associations [134, 135], but the importance of the ratio Firmicutes to
Bacteroidetes remains controversial [136, 137], and some authors state that the
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experimental results are not sufficiently consistent [138]. Interestingly, the exis-
tence of a colitogenic microbiota was demonstrated in T-bet/  RAG2/
deficient mice whose spontaneous ulcerative colitis was horizontally transmissible
to wild-type individuals when co-housed [139]. Although mechanisms by which
dysbiosis trigger intestinal dysfunction are not fully understood, it is known that
they involve the loss of immune tolerance due to local immune homeostasis disrup-
tion and continuous abnormal activation of TLRs [140].
Several authors have suggested that both dietary PACs, which are the substrates
of intestinal bacteria, and the metabolites produced during PACs degradation in the
colon may modulate and induce oscillations in the composition of the microbiota
populations by means of prebiotic and antimicrobial effects against gut pathogenic
microorganisms [141–144]. Dietary PACs, specifically longer polymers, reach the
distal intestine nearly intact, where they become fermentable substrates for the
commensal microbiota [145]. PACs have been associated with prebiotic properties,
boosting the composition of several kinds of probiotics such as Bifidobacterium spp.,
Lactobacillus spp. [146] and the stimulator of mucus production Akkermansia
muciniphila [147, 148]. Nevertheless, current evidence is somewhat controversial as
effects described in different in vivo studies mainly performed with rodents, do not
always agree. This suggests that interactions between PACs and microbiota depend
largely on the botanical source, the types of molecules present in the extracts tested
and the animal model [149].
A recent study by Casanova-Marti et al. [150] found that oral administration of
GSPE in Wistar rats for 8 days resulted in profound changes in the cecal microbiota
composition, reducing diversity indices and the ratio of Firmicutes to Bacteroidetes.
Similar results were found in diet-induced obese Sprague Dawley rats
supplemented with a PAC-rich extract of the Pyracantha fortuneana fruit, although
in this study an increase in microbiota diversity was also reported [81]. GSPE
supplementation in IL-10 deficient mice resulted in an increased abundance of
Bacteroides and Lactobacilli [86]. Xing et al. [148] reported that the administration
of procyanidin B2 in rabbits feeding a high-fat-cholesterol diet, promoted an
increase in the relative abundance of Akkermansia. These authors proposed that the
reduction of metabolic endotoxemia found in animals treated with procyanidin B2
was attributed to the ability of Akkermansia to retain the thickness of the intestinal
mucus layer, thus reducing intestinal permeability and the leakage of LPS into the
circulation [151].
Cueva et al. [146] found that in vitro fermentation of grape-seed monomers and
PACs in human feces resulted in a reduced abundance of Clostridium histolyticum.
Inhibition of the growth of some infectious microorganisms, such as the mentioned
C. histolyticum in the intestine and Helicobacter pylori in the stomach [152], may be
related to the anti-adherence activity that PACs have demonstrated in in vitro
studies [153], as adherence to the epithelium is a prerequisite for colonization and
infection of the intestinal gastrointestinal mucosa.
Finally, phenolic acids and phenyl-γ-valerolactones resulting from the colonic
fermentation of PACs also exhibit a significant bioactivity in cell models and
experimental animals [154]. They therefore may partially account for the beneficial
anti-inflammatory effects reported in intestinal and peripheral tissues in vivo. Fur-
ther research is needed to clarify the importance of these microbial products in
health-promoting properties associated with the intake of PACs.
8. Conclusions and future perspectives
The health-promoting properties of PACs in the intestine are attributed not only
to the antioxidant activity inherent to phenolic compounds, but also to the capacity
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of these phytochemicals to interact with multiple biomolecules, including proteins,
biomembrane lipids, and endotoxins. Bioactivity of PACs is highly structure-
dependent and enriched botanical extracts composed by a large variety of molecular
structures exert a wide range of unrelated physiological effects. In this way, PAC-
rich extracts can modulate kinase activity, several signal transduction pathways
implicated in the inflammatory response and the remodeling of TJs. Flavan-3-ol
monomers and short PAC oligomers are absorbed by enterocytes and immune cells
and exert a direct action on kinases and transcription factors. Bioactivity of larger
oligomers and polymeric PACs do not require direct intestinal absorption and are
able to bind protein receptors on the enterocyte and immune cell surfaces as well as
luminal bacterial endotoxins, thus inhibiting pro-inflammatory signaling and
improving barrier integrity. Due to the negligible absorption of large PACmolecules
in the small intestine, phenyl-γ-valerolactones and phenolic acids produced by the
microbiota metabolism in the colon are thought to play an important role in these
health-promoting effects, and thus need to be further researched.
The barrier-protective properties of PACs are emerging as a potential adjunctive
support to current therapies for managing obesity related intestinal dysfunction and
IBD. However, there have been no large, well-designed clinical trials establishing
the efficacy of these phytochemicals in chronic conditions. At preclinical stages, the
use of animal models is the predominant approach for testing novel therapies for
intestinal dysfunction, although several strategies for replacing animal experiments
have been proposed. As there are still no studies on the impact of PACs on human
intestinal health, ex vivo models of the human intestine could be a more physiolog-
ically reliable alternative to human cell lines and an alternative to animal experi-
mentation in preclinical development.
Acknowledgements
C. González-Quilen has received financial support through a FI-AGAUR grant
from the Generalitat de Catalunya. M. Pinent and X. Terra are Serra-Húnter fellows
at the Universitat Rovira i Virgili, Tarragona, Spain.
Conflicts of interest
The authors declare no conflict of interest.
Funding
This work was funded by the Spanish Ministerio de Economía y Competitividad
(Grant: AGL2017-83477-R).
16
Weight Management
Author details
Carlos González-Quilen, Esther Rodríguez-Gallego, Raúl Beltrán-Debón,
Montserrat Pinent, Anna Ardévol, Maria Teresa Blay and Ximena Terra*
MoBioFood Research Group, Departament de Bioquímica i Biotecnologia,
Universitat Rovira i Virgili, Tarragona, Spain
*Address all correspondence to: ximena.terra@urv.cat
© 2020TheAuthor(s). Licensee IntechOpen. This chapter is distributed under the terms
of theCreativeCommonsAttribution License (http://creativecommons.org/licenses/
by/3.0),which permits unrestricted use, distribution, and reproduction in anymedium,
provided the original work is properly cited.
17
Beneficial Effects of Proanthocyanidins on Intestinal Permeability and Its Relationship…
DOI: http://dx.doi.org/10.5772/intechopen.91212
References
[1] Chelakkot C, Ghim J, Ryu SH.
Mechanisms regulating intestinal barrier
integrity and its pathological
implications. Experimental & Molecular
Medicine. 2018;50:103
[2] Fukui H. Increased intestinal
permeability and decreased barrier
function: Does it really influence the risk
of inflammation? Inflammatory
Intestinal Diseases. 2016;1:135-145. DOI:
10.1159/000447252
[3] Clemente-Postigo M, Oliva-Olivera
W, Coin-Aragüez L, Ramos-Molina B,
Giraldez-Perez RM, Lhamyani S, et al.
Metabolic endotoxemia promotes
adipose dysfunction and inflammation
in human obesity. American Journal of
Physiology-Endocrinology and
Metabolism. 2019;316:E319-E332. DOI:
10.1152/ajpendo.00277.2018
[4]Harvey A. Strategies for discovering
drugs from previously unexplored
natural products. Drug Discovery
Today. 2000;5:294-300
[5] Costa C, Tsatsakis A, Mamoulakis C,
Teodoro M, Briguglio G, Caruso E, et al.
Current evidence on the effect of
dietary polyphenols intake on chronic
diseases. Food and Chemical
Toxicology. 2017;110:286-299
[6] Smeriglio A, Barreca D, Bellocco E,
Trombetta D. Proanthocyanidins and
hydrolysable tannins: Occurrence,
dietary intake and pharmacological
effects. British Journal of Pharmacology.
2017;174:1244-1262. DOI: 10.1111/
bph.13630
[7] Bladé C, Aragonès G, Arola-Arnal A,
Muguerza B, Bravo FI, Salvadó MJ, et al.
Proanthocyanidins in health and
disease. BioFactors. 2016;42:5-12. DOI:
10.1002/biof.1249
[8] Gil-Cardoso K, Ginés I, Pinent M,
Ardévol A, Blay M, Terra X. The
co-administration of proanthocyanidins
and an obesogenic diet prevents the
increase in intestinal permeability and
metabolic endotoxemia derived to the
diet. The Journal of Nutritional
Biochemistry. 2018;62:35-42. DOI:
10.1016/J.JNUTBIO.2018.07.012
[9] Gil-Cardoso K, Ginés I, Pinent M,
Ardévol A, Blay M, Terra X. Effects of
flavonoids on intestinal inflammation,
barrier integrity and changes in gut
microbiota during diet-induced obesity.
Nutrition Research Reviews. 2016;29:
1-15. DOI: 10.1017/S0954422416000159
[10]Wu H, Luo T, Li YM, Gao ZP,
Zhang KQ, Song JY, et al. Granny Smith
apple procyanidin extract upregulates
tight junction protein expression and
modulates oxidative stress and
inflammation in lipopolysaccharide-
induced Caco-2 cells. Food & Function.
2018;9:3321-3329. DOI: 10.1039/
c8fo00525g
[11] Terra X, Valls J, Vitrac X, Mérrillon
J-M, Arola L, Ardèvol A, et al. Grape-
seed procyanidins act as
antiinflammatory agents in endotoxin-
stimulated RAW 264.7 macrophages by
inhibiting NFkB signaling pathway.
Journal of Agricultural and Food
Chemistry. 2007;55:4357-4365. DOI:
10.1021/jf0633185
[12]Martinez-Micaelo N, González-
Abuín N, Pinent M, Ardévol A, Blay M.
Procyanidin B2 inhibits inflammasome-
mediated IL-1β production in
lipopolysaccharide-stimulated
macrophages. Molecular Nutrition &
Food Research. 2015;59:262-269. DOI:
10.1002/mnfr.201400370
[13]Gil-Cardoso K, Comitato R, Ginés I,
Ardévol A, Pinent M, Virgili F, et al.
Protective effect of proanthocyanidins
in a rat model of mild intestinal
inflammation and impaired intestinal
18
Weight Management
permeability induced by LPS. Molecular
Nutrition & Food Research. 2019;63:
1800720. DOI: 10.1002/mnfr.
201800720
[14] Gil-Cardoso K, Ginés I, Pinent M,
Ardévol A, Arola L, Blay M, et al.
Chronic supplementation with dietary
proanthocyanidins protects from diet-
induced intestinal alterations in obese
rats. Molecular Nutrition & Food
Research. 2017;61:1601039. DOI:
10.1002/mnfr.201601039
[15]González-Quilen C, Gil-Cardoso K,
Ginés I, Beltrán-Debón R, Pinent M,
Ardévol A, et al. Grape-seed
proanthocyanidins are able to reverse
intestinal dysfunction and metabolic
endotoxemia induced by a cafeteria
diet in wistar rats. Nutrients.
2019;11:pii: E979. DOI: 10.3390/
nu11050979
[16] Allaire JM, Crowley SM, Law HT,
Chang SY, Ko HJ, Vallance BA. The
intestinal epithelium: Central
coordinator of mucosal immunity.
Trends in Immunology. 2018;39:
677-696
[17] Bischoff SC, Barbara G,
Buurman W, Ockhuizen T, Schulzke J-
D, Serino M, et al. Intestinal
permeability—A new target for disease
prevention and therapy. BMC
Gastroenterology. 2014;14:189. DOI:
10.1186/s12876-014-0189-7
[18] Birchenough GMH,
Johansson MEV, Gustafsson JK,
Bergström JH, Hansson GC. New
developments in goblet cell mucus
secretion and function. Mucosal
Immunology. 2015;8:712-719. DOI:
10.1038/mi.2015.32
[19]Nakamura Y, Kimura S, Hase K. M
cell-dependent antigen uptake on
follicle-associated epithelium for
mucosal immune surveillance.
Inflammation and Regeneration. 2018;
38:15. DOI: 10.1186/s41232-018-0072-y
[20] Fiocchi C. What is “physiological”
intestinal inflammation and how does it
differ from “pathological”
inflammation? Inflammatory Bowel
Diseases. 2008;14:S77-S78. DOI:
10.1097/00054725-200810001-00040
[21] Belkaid Y, Harrison OJ. Homeostatic
immunity and the microbiota.
Immunity. 2017;46:562-576
[22]Ulluwishewa D, Anderson RC,
McNabb WC, Moughan PJ, Wells JM,
Roy NC. Regulation of tight junction
permeability by intestinal bacteria and
dietary components. The Journal of
Nutrition. 2011;141:769-776. DOI:
10.3945/jn.110.135657
[23] Luo H, Guo P, Zhou Q. Role of
TLR4/NF-κB in damage to intestinal
mucosa barrier function and bacterial
translocation in rats exposed to hypoxia.
PLoS One. 2012;7:e46291. DOI: 10.1371/
journal.pone.0046291
[24] Suzuki T. Regulation of intestinal
epithelial permeability by tight
junctions. Cellular and Molecular Life
Sciences. 2013;70:631-659. DOI:
10.1007/s00018-012-1070-x
[25] Suzuki M, Nagaishi T, Yamazaki M,
Onizawa M, Watabe T, Sakamaki Y,
et al. Myosin light chain kinase
expression induced via tumor necrosis
factor receptor 2 signaling in the
epithelial cells regulates the
development of colitis-associated
carcinogenesis. PLoS One. 2014;9:
e88369. DOI: 10.1371/journal.
pone.0088369
[26] Barreau F, Hugot JP. Intestinal
barrier dysfunction triggered by
invasive bacteria. Current Opinion in
Microbiology. 2014;17:91-98. DOI:
10.1016/j.mib.2013.12.003
[27] Al-Sadi R, Ye D, Dokladny K,
Ma TY. Mechanism of IL-1beta-induced
increase in intestinal epithelial tight
junction permeability. Journal of
19
Beneficial Effects of Proanthocyanidins on Intestinal Permeability and Its Relationship…
DOI: http://dx.doi.org/10.5772/intechopen.91212
Immunology. 2008;180:5653-5661. DOI:
180/8/5653 [pii]
[28]Al-Sadi R, Guo S, Ye D, Dokladny K,
Alhmoud T, Ereifej L, et al. Mechanism
of IL-1βmodulation of intestinal
epithelial barrier involves p38 kinase
and activating transcription factor-2
activation. Journal of Immunology.
2013;190:6596-6606. DOI: 10.4049/
jimmunol.1201876
[29] Ye D, Ma TY. Cellular and
molecular mechanisms that mediate
basal and tumour necrosis factor-alpha-
induced regulation of myosin light chain
kinase gene activity. Journal of Cellular
and Molecular Medicine. 2008;12:
1331-1346. DOI: 10.1111/
j.1582-4934.2008.00302.x
[30] Luo H, Guo P, Zhou Q. Role of
TLR4/NF-kappaB in damage to
intestinal mucosa barrier function and
bacterial translocation in rats exposed to
hypoxia. PLoS One. 2012;7:e46291. DOI:
10.1371/journal.pone.0046291
[31] Laugerette F, Furet J-P, Debard C,
Daira P, Loizon E, Geloen a, et al. Oil
composition of high-fat diet affects
metabolic inflammation differently in
connection with endotoxin receptors in
mice. American Journal of Physiology-
Endocrinology and Metabolism. 2012;
302:E374-E386. DOI: 10.1152/
ajpendo.00314.2011
[32] Li Q, Verma IM. NF-kappaB
regulation in the immune system.
Nature Reviews. Immunology. 2002;2:
725-734. DOI: 10.1038/nri910
[33]Hayden MS, West AP, Ghosh S. NF-
kappaB and the immune response.
Oncogene. 2006;25:6758-6780. DOI:
10.1038/sj.onc.1209943
[34] Pahl HL. Activators and target genes
of Rel/NF-kappaB transcription factors.
Oncogene. 1999;18:6853-6866. DOI:
10.1038/sj.onc.1203239
[35] Toumi R, Soufli I, Rafa H,
Belkhelfa M, Biad A, Touil-Boukoffa C.
Probiotic bacteria Lactobacillus and
Bifidobacterium attenuate inflammation
in dextran sulfate sodium-induced
experimental colitis in mice.
International Journal of
Immunopathology and Pharmacology.
2014;27:615-627
[36]Wang W, Xia T, Yu X. Wogonin
suppresses inflammatory response and
maintains intestinal barrier function via
TLR4-MyD88-TAK1-mediated NF-κB
pathway in vitro. Inflammation
Research. 2015;64:423-431. DOI:
10.1007/s00011-015-0822-0
[37]Kolios G, Valatas V,Ward SG. Nitric
oxide in inflammatory bowel disease: A
universal messenger in an unsolved
puzzle. Immunology. 2004;113:427-437.
DOI: 10.1111/j.1365-2567.2004.01984.x
[38]Martinez-Micaelo N, Gonzalez-
Abuin N, Terra X, Richart C, Ardevol A,
Pinent M, et al. Omega-3
docosahexaenoic acid and procyanidins
inhibit cyclo-oxygenase activity and
attenuate NF-kappaB activation through
a p105/p50 regulatory mechanism in
macrophage inflammation. The
Biochemical Journal. 2012;441:653-663.
DOI: 10.1042/BJ20110967
[39]Du CYQ, Choi RCY, Dong TTX,
Lau DTW, Tsim KWK. Yu Ping Feng
San, an ancient Chinese herbal
decoction, regulates the expression of
inducible nitric oxide synthase and
cyclooxygenase-2 and the activity of
intestinal alkaline phosphatase in
cultures. PLoS One. 2014;9:e100382.
DOI: 10.1371/journal.pone.0100382
[40] Ananthakrishnan AN,
Bernstein CN, Iliopoulos D,
Macpherson A, Neurath MF, Ali RAR,
et al. Environmental triggers in IBD: A
review of progress and evidence. Nature
Reviews. Gastroenterology &
Hepatology. 2018;15:39-49
20
Weight Management
[41]Huang S, Rutkowsky JM,
Snodgrass RG, Ono-Moore KD,
Schneider DA, Newman JW, et al.
Saturated fatty acids activate TLR-
mediated proinflammatory signaling
pathways. Journal of Lipid Research.
2012;53:2002-2013. DOI: 10.1194/jlr.
D029546
[42]Wong SW, Kwon MJ, Choi AMK,
Kim HP, Nakahira K, Hwang DH. Fatty
acids modulate toll-like receptor 4
activation through regulation of
receptor dimerization and recruitment
into lipid rafts in a reactive oxygen
species-dependent manner. The Journal
of Biological Chemistry. 2009;284:
27384-27392. DOI: 10.1074/jbc.
M109.044065
[43]Gil-Cardoso K, Ginés I, Pinent M,
Ardévol A, Terra X, Blay M. A cafeteria
diet triggers intestinal inflammation and
oxidative stress in obese rats. The British
Journal of Nutrition. 2017;117:218. DOI:
10.1017/S0007114516004608
[44] Cani PD, Bibiloni R, Knauf C,
Waget A, Neyrinck AM, Delzenne NM,
et al. Changes in gut microbiota control
metabolic endotoxemia-induced
inflammation in high-fat diet-induced
obesity and diabetes in mice. Diabetes.
2008;57:1470-1481. DOI: 10.2337/
db07-1403
[45] Serrano J, Puupponen-Pimiä R,
Dauer A, Aura AM, Saura-Calixto F.
Tannins: Current knowledge of food
sources, intake, bioavailability and
biological effects. Molecular
Nutrition & Food Research. 2009;53:
310-329. DOI: 10.1002/mnfr.
200900039
[46] Bittner K, Rzeppa S, Humpf H-U.
Distribution and quantification of
flavan-3-ols and procyanidins with low
degree of polymerization in nuts,
cereals, and legumes. Journal of
Agricultural and Food Chemistry. 2013;
61:9148-9154. DOI: 10.1021/jf4024728
[47] Rue EA, Rush MD, van
Breemen RB. Procyanidins: A
comprehensive review encompassing
structure elucidation via mass
spectrometry. Phytochemistry Reviews.
2018;17:1-16. DOI: 10.1007/s11101-017-
9507-3
[48]Wang Y, Chung S-J, Song WO,
Chun OK. Estimation of daily
proanthocyanidin intake and major food
sources in the U.S. diet. The Journal of
Nutrition. 2011;141:447-452. DOI:
10.3945/jn.110.133900
[49] Jun S, Shin S, Joung H. Estimation of
dietary flavonoid intake and major food
sources of Korean adults. The British
Journal of Nutrition. 2016;115:480-489.
DOI: 10.1017/S0007114515004006
[50] Zamora-Ros R, Biessy C,
Rothwell JA, Monge A, Lajous M,
Scalbert A, et al. Dietary polyphenol
intake and their major food sources in the
Mexican Teachers’ Cohort. The British
Journal of Nutrition. 2018;120:353-360.
DOI: 10.1017/S0007114518001381
[51] Vogiatzoglou A, Mulligan AA,
Luben RN, Lentjes MAH, Heiss C,
Kelm M, et al. Assessment of the
dietary intake of total flavan-3-ols,
monomeric flavan-3-ols,
proanthocyanidins and theaflavins in
the European Union. The British Journal
of Nutrition. 2014;111:1463-1473. DOI:
10.1017/S0007114513003930
[52] Zamora-Ros R, Knaze V,
Rothwell JA, Hémon B, Moskal A,
Overvad K, et al. Dietary polyphenol
intake in Europe: The European
Prospective Investigation into Cancer
and Nutrition (EPIC) Study. European
Journal of Nutrition. 2016;55:1359-1375.
DOI: 10.1007/s00394-015-0950-x
[53] Knaze V, Zamora-Ros R,
Luján-Barroso L, Romieu I, Scalbert A,
Slimani N, et al. Intake estimation of
total and individual flavan-3-ols,
21
Beneficial Effects of Proanthocyanidins on Intestinal Permeability and Its Relationship…
DOI: http://dx.doi.org/10.5772/intechopen.91212
proanthocyanidins and theaflavins,
their food sources and determinants in
the European Prospective Investigation
into Cancer and Nutrition (EPIC) study.
The British Journal of Nutrition. 2012;
108:1095-1108. DOI: 10.1017/
S0007114511006386
[54] Rios LY, Bennett RN, Lazarus SA,
Remesy C, Scalbert A, Williamson G.
Cocoa procyanidins are stable during
gastric transit in humans. The American
Journal of Clinical Nutrition. 2002;76:
1106-1110
[55]Donovan JL, Crespy V, Manach C,
Morand C, Besson C, Scalbert A, et al.
Catechin is metabolized by both the
small intestine and liver of rats. The
Journal of Nutrition. 2001;131:1753-1757.
DOI: 10.1093/jn/131.6.1753
[56] Stalmach A, Mullen W, Steiling H,
Williamson G, Lean MEJ, Crozier A.
Absorption, metabolism, and excretion
of green tea flavan-3-ols in humans with
an ileostomy. Molecular Nutrition &
Food Research. 2010;54:323-334. DOI:
10.1002/mnfr.200900194
[57] Thilakarathna SH, Vasantha
Rupasinghe HP. Flavonoid
bioavailability and attempts for
bioavailability enhancement. Nutrients.
2013;5:3367-3387. DOI: 10.3390/
nu5093367
[58] Rein D, Lotito S, Holt RR, Keen CL,
Schmitz HH, Fraga CG. Epicatechin in
human plasma: In vivo determination
and effect of chocolate consumption on
plasma oxidation status. The Journal of
Nutrition. 2000;130:2109S-2114S. DOI:
10.1093/jn/130.8.2109S
[59]Ullmann U, Haller J, Decourt JP,
Girault N, Girault J, Richard-Caudron
AS, et al. A single ascending dose study
of epigallocatechin gallate in healthy
volunteers. The Journal of International
Medical Research. 2003;31:88-101. DOI:
10.1177/147323000303100205
[60]Wiese S, Esatbeyoglu T,
Winterhalter P, Kruse HP, Winkler S,
Bub A, et al. Comparative biokinetics
and metabolism of pure monomeric,
dimeric, and polymeric flavan-3-ols: A
randomized cross-over study in
humans. Molecular Nutrition & Food
Research. 2015;59:610-621. DOI:
10.1002/mnfr.201400422
[61]Deprez S, Mila I, Huneau J-F,
Tome D, Scalbert A. Transport of
proanthocyanidin dimer, trimer, and
polymer across monolayers of human
intestinal epithelial Caco-2 cells.
Antioxidants & Redox Signaling. 2001;
3:957-967. DOI: 10.1089/152308601
317203503
[62] Zumdick S, Deters A, Hensel A. In
vitro intestinal transport of oligomeric
procyanidins (DP 2 to 4) across
monolayers of Caco-2 cells. Fitoterapia.
2012;83:1210-1217. DOI: 10.1016/j.
fitote.2012.06.013
[63]Mendoza-Wilson AM, Carmelo-
Luna FJ, Astiazarán-García H,Mata-Haro
V, Espinosa-Plascencia A, del Carmen
Bermúdez-Almada M, et al. Absorption
of dimers, trimers and tetramers of
procyanidins present in apple skin by
IEC-18 cell monolayers. Journal of
Functional Foods. 2016;27:386-391. DOI:
10.1016/J.JFF.2016.09.020.
[64] Shoji T, Masumoto S, Moriichi N,
Akiyama H, Kanda T, Ohtake Y, et al.
Apple procyanidin oligomers absorption
in rats after oral administration:
Analysis of procyanidins in plasma
using the porter method and high-
performance liquid chromatography/
tandem mass spectrometry. Journal of
Agricultural and Food Chemistry. 2006;
54:884-892. DOI: 10.1021/jf052260b
[65] Serra A, MacI A, Romero MP,
Valls J, Bladé C, Arola L, et al.
Bioavailability of procyanidin dimers
and trimers and matrix food effects in
in vitro and in vivo models. The British
Journal of Nutrition. 2010;103:944-952.
DOI: 10.1017/S0007114509992741
22
Weight Management
[66] Sano A, Yamakoshi J, Tokutake S,
Tobe K, Kubota Y, Kikuchi M.
Procyanidin B1 is detected in human
serum after intake of proanthocyanidin-
rich grape seed extract. Bioscience,
Biotechnology, and Biochemistry. 2003;
67:1140-1143
[67]Ottaviani JI, Kwik-Uribe C,
Keen CL, Schroeter H. Intake of dietary
procyanidins does not contribute to the
pool of circulating flavanols in humans.
The American Journal of Clinical
Nutrition. 2012;95:851-858. DOI:
10.3945/ajcn.111.028340
[68] Tsang C, Auger C, Mullen W,
Bornet A, Rouanet J-M, Crozier A, et al.
The absorption, metabolism and
excretion of flavan-3-ols and
procyanidins following the ingestion of
a grape seed extract by rats. The British
Journal of Nutrition. 2005;94:170-181
[69]Gu L, House SE, Rooney L,
Prior RL. Sorghum bran in the diet dose
dependently increased the excretion of
catechins and microbial-derived
phenolic acids in female rats. Journal of
Agricultural and Food Chemistry. 2007;
55:5326-5334. DOI: 10.1021/jf070100p
[70] Appeldoorn MM, Vincken JP,
Aura AM, Hollman PCH, Gruppen H.
Procyanidin dimers are metabolized by
human microbiota with 2-(3,4-
dihydroxyphenyl)acetic acid and 5-(3,4-
dihydroxyphenyl)-γ-valerolactone as
the major metabolites. Journal of
Agricultural and Food Chemistry. 2009;
57:1084-1092. DOI: 10.1021/jf803059z
[71] Castello F, Costabile G, Bresciani L,
Tassotti M, Naviglio D, Luongo D, et al.
Bioavailability and pharmacokinetic
profile of grape pomace phenolic
compounds in humans. Archives of
Biochemistry and Biophysics. 2018;646:
1-9. DOI: 10.1016/j.abb.2018.03.021
[72] Trošt K, Ulaszewska MM,
Stanstrup J, Albanese D, De Filippo C,
Tuohy KM, et al. Host: Microbiome
co-metabolic processing of dietary
polyphenols—An acute, single blinded,
cross-over study with different doses of
apple polyphenols in healthy subjects.
Food Research International. 2018;112:
108-128. DOI: 10.1016/j.foodres.
2018.06.016
[73]Margalef M, Pons Z, Bravo FI,
Muguerza B, Arola-Arnal A. Tissue
distribution of rat flavanol metabolites
at different doses. The Journal of
Nutritional Biochemistry. 2015;26:
987-995. DOI: 10.1016/j.jnutbio.2015.
04.006
[74] Yoshioka Y, Akiyama H, Nakano M,
Shoji T, Kanda T, Ohtake Y, et al. Orally
administered apple procyanidins protect
against experimental inflammatory
bowel disease in mice. International
Immunopharmacology. 2008;8:
1802-1807. DOI: 10.1016/j.intimp.
2008.08.021
[75]Denis M-C, Desjardins Y, Furtos A,
Marcil V, Dudonné S, Montoudis A,
et al. Prevention of oxidative stress,
inflammation and mitochondrial
dysfunction in the intestine by different
cranberry phenolic fractions. Clinical
Science. 2015;128:197-212. DOI:
10.1042/CS20140210
[76] Erlejman AG, Jaggers G, Fraga CG,
Oteiza PI. TNFα-induced NF-κB
activation and cell oxidant production
are modulated by hexameric
procyanidins in Caco-2 cells. Archives of
Biochemistry and Biophysics. 2008;476:
186-195. DOI: 10.1016/j.abb.2008.
01.024
[77]Gentile C, Perrone A, Attanzio A,
Tesoriere L, Livrea MA. Sicilian
pistachio (Pistacia vera L.) nut inhibits
expression and release of inflammatory
mediators and reverts the increase of
paracellular permeability in IL-1β-
exposed human intestinal epithelial
cells. European Journal of Nutrition.
2015;54:811-821. DOI: 10.1007/
s00394-014-0760-6
23
Beneficial Effects of Proanthocyanidins on Intestinal Permeability and Its Relationship…
DOI: http://dx.doi.org/10.5772/intechopen.91212
[78] Bitzer ZT, Glisan SL, Dorenkott MR,
Goodrich KM, Ye L, O’Keefe SF, et al.
Cocoa procyanidins with different
degrees of polymerization possess
distinct activities in models of colonic
inflammation. The Journal of
Nutritional Biochemistry. 2015;26:
827-831. DOI: 10.1016/j.
jnutbio.2015.02.007
[79] Bianchi MG, Chiu M, Taurino G,
Brighenti F, Del Rio D, Mena P, et al.
Catechin and Procyanidin B2 modulate
the expression of tight junction proteins
but do not protect from inflammation-
induced changes in permeability in
human intestinal cell monolayers.
Nutrients. 2019;11:2271. DOI: 10.3390/
nu11102271
[80]Wong X, Carrasco-Pozo C,
Escobar E, Navarrete P, Blachier F,
Andriamihaja M, et al. Deleterious effect
of p-cresol on human colonic epithelial
cells prevented by proanthocyanidin-
containing polyphenol extracts from
fruits and proanthocyanidin bacterial
metabolites. Journal of Agricultural and
Food Chemistry. 2016;64:3574-3583.
DOI: 10.1021/acs.jafc.6b00656
[81] Xu H, Zhao C, Li Y, Liu R, Ao M,
Li F, et al. The ameliorative effect of the:
Pyracantha fortuneana (Maxim.) H. L. Li
extract on intestinal barrier dysfunction
through modulating glycolipid digestion
and gut microbiota in high fat diet-fed
rats. Food & Function. 2019;10:
6517-6532. DOI: 10.1039/c9fo01599j
[82]Wang Y-H, Yang X-L, Wang L, Cui
M-X, Cai Y-Q, Li X, et al. Effects of
proanthocyanidins from grape seed on
treatment of recurrent ulcerative colitis
in rats. Canadian Journal of Physiology
and Pharmacology. 2010;898:888-898.
DOI: 10.1139/Y10-071
[83]Wang Y-H, Ge B, Yang X-L, Zhai J,
Yang L-N, Wang X-X, et al.
Proanthocyanidins from grape seeds
modulates the nuclear factor-kappa B
signal transduction pathways in rats
with TNBS-induced recurrent
ulcerative colitis. International
Immunopharmacology. 2011;11:
1620-1627. DOI: 10.1016/j.intimp.2011.
05.024
[84] Li X, Yang X, Cai Y, Qin H,Wang L,
Wang Y, et al. Proanthocyanidins from
grape seeds modulate the NF-κB signal
transduction pathways in rats with
TNBS-induced ulcerative colitis.
Molecules. 2011;16:6721-6731. DOI:
10.3390/molecules16086721
[85] Chen L, You Q, Hu L, Gao J,
Meng Q, Liu W, et al. The antioxidant
procyanidin reduces reactive oxygen
species signaling in macrophages and
ameliorates experimental colitis in mice.
Frontiers in Immunology. 2018;8:1910.
DOI: 10.3389/fimmu.2017.01910
[86]Wang H, Xue Y, Zhang H, Huang Y,
Yang G, Du M, et al. Dietary grape seed
extract ameliorates symptoms of
inflammatory bowel disease in IL10-
deficient mice. Molecular Nutrition &
Food Research. 2013;57:2253-2257. DOI:
10.1002/mnfr.201300146
[87] Bibi S, Kang Y, Yang G, Zhu M-J.
Grape seed extract improves small
intestinal health through suppressing
inflammation and regulating alkaline
phosphatase in IL-10-deficient mice.
Journal of Functional Foods. 2016;20:
245-252. DOI: 10.1016/J.JFF.2015.10.021
[88]He X, Sun LM. Dietary intake
of flavonoid subclasses and risk of
colorectal cancer: Evidence from
population studies. Oncotarget. 2016;7:
26617-26627. DOI: 10.18632/
oncotarget.8562
[89] Sambuy Y, De Angelis I, Ranaldi G,
Scarino ML, Stammati A, Zucco F. The
Caco-2 cell line as a model of the
intestinal barrier: Influence of cell and
culture-related factors on Caco-2 cell
functional characteristics. Cell Biology
and Toxicology. 2005;21:1-26
24
Weight Management
[90] Kämpfer AAM, Urbán P, Gioria S,
Kanase N, Stone V, Kinsner-Ovaskainen
A. Development of an in vitro co-
culture model to mimic the human
intestine in healthy and diseased state.
Toxicology in Vitro. 2017;45:31-43. DOI:
10.1016/j.tiv.2017.08.011
[91] Chassaing B, Rolhion N, De
Vallée A, Salim SY, Prorok-Hamon M,
Neut C, et al. Crohn disease-associated
adherent-invasive E. coli bacteria target
mouse and human Peyer’s patches via
long polar fimbriae. The Journal of
Clinical Investigation. 2011;121:966-975.
DOI: 10.1172/JCI44632.
[92] Goh JY, Weaver RJ, Dixon L,
Platt NJ, Roberts RA. Development and
use of in vitro alternatives to animal
testing by the pharmaceutical industry
1980–2013. Toxicology Research
(Cambridge). 2015;4:1297-1307. DOI:
10.1039/c5tx00123d
[93] Kang TH, Kim HJ. Farewell to
animal testing: Innovations on human
intestinal microphysiological systems.
Micromachines. 2016;7:107
[94] Randhawa PK, Singh K, Singh N,
Jaggi AS. A review on chemical-induced
inflammatory bowel disease models in
rodents. The Korean Journal of
Physiology & Pharmacology. 2014;18:
279-288. DOI: 10.4196/
kjpp.2014.18.4.279
[95]Hidalgo IJ, Raub TJ, Borchardt RT.
Characterization of the human colon
carcinoma cell line (Caco-2) as a model
system for intestinal epithelial
permeability. Gastroenterology. 1989;
96:736-749. DOI: 10.1016/S0016-5085
(89)80072-1
[96] Srinivasan B, Kolli AR, Esch MB,
Abaci HE, Shuler ML, Hickman JJ. TEER
measurement techniques for in vitro
barrier model systems. Journal of
Laboratory Automation. 2015;20:
107-126. DOI: 10.1177/
2211068214561025
[97] Sampey BP, Vanhoose AM,
Winfield HM, Freemerman AJ,
Muehlbauer MJ, Fueger PT, et al.
Cafeteria diet is a robust model of
human metabolic syndrome with liver
and adipose inflammation: Comparison
to high-fat diet. Obesity (Silver Spring).
2011;19:1109-1117. DOI: 10.1038/
oby.2011.18
[98]Ginés I, Gil-Cardoso K, Serrano J,
Casanova-Martí À, Blay M, Pinent M,
et al. Effects of an intermittent grape-
seed proanthocyanidin (GSPE)
treatment on a cafeteria diet obesogenic
challenge in rats. Nutrients. 2018;10:315.
DOI: 10.3390/nu10030315
[99] Baselga-Escudero L, Pascual-
Serrano A, Ribas-Latre A, Casanova E,
Salvadó MJ, Arola L, et al. Long-term
supplementation with a low dose of
proanthocyanidins normalized liver
miR-33a and miR-122 levels in high-fat
diet-induced obese rats. Nutrition
Research. 2015;35:337-345. DOI:
10.1016/j.nutres.2015.02.008
[100]Margalef M, Pons Z, Iglesias-
Carres L, Arola L, Muguerza B, Arola-
Arnal A. Gender-related similarities and
differences in the body distribution of
grape seed flavanols in rats. Molecular
Nutrition & Food Research. 2016;60:
760-772. DOI: 10.1002/mnfr.201500717
[101] Terra X, Pallarés V, Ardèvol A,
Bladé C, Fernández-Larrea J, Pujadas G,
et al. Modulatory effect of grape-seed
procyanidins on local and systemic
inflammation in diet-induced obesity
rats. The Journal of Nutritional
Biochemistry. 2011;22:380-387. DOI:
10.1016/j.jnutbio.2010.03.006
[102] Li X-L, Cai Y-Q, Qin H, Wu Y-J.
Therapeutic effect and mechanism of
proanthocyanidins from grape seeds in
rats with TNBS-induced ulcerative
colitis. Canadian Journal of Physiology
and Pharmacology. 2008;86:841-849.
DOI: 10.1139/Y08-089
25
Beneficial Effects of Proanthocyanidins on Intestinal Permeability and Its Relationship…
DOI: http://dx.doi.org/10.5772/intechopen.91212
[103]Hollman PCH, Cassidy A,
Comte B, Heinonen M, Richelle M,
Richling E, et al. The biological
relevance of direct antioxidant effects of
polyphenols for cardiovascular health in
humans is not established. The Journal
of Nutrition. 2011;141:989S-1009S. DOI:
10.3945/jn.110.131490
[104] Tsilingiri K, Sonzogni A,
Caprioli F, Rescigno M. A novel method
for the culture and polarized stimulation
of human intestinal mucosa explants.
Journal of Visualized Experiments. 2013:
e4368. DOI: 10.3791/4368
[105] Vadstrup K, Galsgaard ED,
Gerwien J, Vester-Andersen MK,
Pedersen JS, Rasmussen J, et al.
Validation and optimization of an
ex vivo assay of intestinal mucosal
biopsies in Crohn’s disease: Reflects
inflammation and drug effects. PLoS
One. 2016;11:e0155335. DOI: 10.1371/
journal.pone.0155335
[106] Sjöberg Å, Lutz M, Tannergren C,
Wingolf C, Borde A, Ungell A-L.
Comprehensive study on regional
human intestinal permeability and
prediction of fraction absorbed of drugs
using the Ussing chamber technique.
European Journal of Pharmaceutical
Sciences. 2013;48:166-180. DOI:
10.1016/J.EJPS.2012.10.007
[107] Geraedts MCP, Troost FJ, De
Ridder RJ, Bodelier AGL, Masclee AAM,
Saris WHM. Validation of Ussing
chamber technology to study satiety
hormone release from human duodenal
specimens. Obesity. 2012;20:678-682.
DOI: 10.1038/oby.2011.104
[108]Wood MW, Breitschwerdt EB,
Nordone SK, Linder KE, Gookin JL.
Uropathogenic E. coli promote a
paracellular urothelial barrier defect
characterized by altered tight junction
integrity, epithelial cell sloughing and
cytokine release. Journal of Comparative
Pathology. 2012;147:11-19. DOI:
10.1016/j.jcpa.2011.09.005
[109] Ray S, Bagchi D, Lim PM,
Bagchi M, Gross SM, Kothari SC, et al.
Acute and long-term safety evaluation
of a novel IH636 grape seed
proanthocyanidin extract. Research
Communications in Molecular
Pathology and Pharmacology. 2001;109:
165-197
[110] Yamakoshi J, Saito M, Kataoka S,
Kikuchi M. Safety evaluation of
proanthocyanidin-rich extract from
grape seeds. Food and Chemical
Toxicology. 2002;40:599-607. DOI:
10.1016/s0278-6915(02)00006-6
[111] Lluís L, Muñoz M, Rosa Nogués M,
Sánchez-Martos V, Romeu M, Giralt M,
et al. Toxicology evaluation of a
procyanidin-rich extract from grape
skins and seeds. Food and Chemical
Toxicology. 2011;49:1450-1454. DOI:
10.1016/j.fct.2011.03.042
[112]Wong X, Madrid AM, Tralma K,
Castillo R, Carrasco-Pozo C,
Navarrete P, et al. Polyphenol
extracts interfere with bacterial
lipopolysaccharide in vitro and decrease
postprandial endotoxemia in human
volunteers. Journal of Functional Foods.
2016;26:406-417. DOI: 10.1016/J.
JFF.2016.08.011
[113] Cani PD, Osto M, Geurts L,
Everard A. Involvement of gut
microbiota in the development of low-
grade inflammation and type 2 diabetes
associated with obesity. Gut Microbes.
2012;3:279-288
[114] Butler LG. Effects of condensed
tannin on animal nutrition. In:
Chemistry and Significance of
Condensed Tannins. US: Springer; 1989.
pp. 391-402
[115] Chung KT, Wong TY, Wei CI,
Huang YW, Lin Y. Tannins and human
health: A review. Critical Reviews in
Food Science and Nutrition. 1998;38:
421-464. DOI: 10.1080/
10408699891274273
26
Weight Management
[116] Brás NF, Gonçalves R,
Fernandes PA, Mateus N, Ramos MJ, De
Freitas V. Understanding the binding of
procyanidins to pancreatic elastase by
experimental and computational
methods. Biochemistry. 2010;49:
5097-5108. DOI: 10.1021/bi100410q
[117]De Freitas V, Mateus N. Structural
features of procyanidin interactions
with salivary proteins. Journal of
Agricultural and Food Chemistry. 2001;
49:940-945. DOI: 10.1021/jf000981z
[118] Zhu W, Xiong L, Peng J, Deng X,
Gao J, Li CM. Molecular insight into
affinities of gallated and nongallated
proanthocyanidins dimers to lipid
bilayers. Scientific Reports. 2016;6:
37680. DOI: 10.1038/srep37680
[119] Verstraeten SV, Jaggers GK,
Fraga CG, Oteiza PI. Procyanidins can
interact with Caco-2 cell membrane
lipid rafts: Involvement of cholesterol.
Biochimica et Biophysica Acta,
Biomembranes. 2013;1828:2646-2653.
DOI: 10.1016/j.bbamem.2013.07.023
[120] Yang G, Bibi S, Du M, Suzuki T,
Zhu MJ. Regulation of the intestinal
tight junction by natural polyphenols: A
mechanistic perspective. Critical
Reviews in Food Science and Nutrition.
2017;57:3830-3839. DOI: 10.1080/
10408398.2016.1152230
[121] Cunningham KE, Turner JR.
Myosin light chain kinase: Pulling the
strings of epithelial tight junction
function. Annals of the New York
Academy of Sciences. 2012;1258:34-42.
DOI: 10.1111/j.1749-6632.2012.06526.x
[122]Marchiando AM, Shen L,
Graham WV, Edelblum KL,
Duckworth CA, Guan Y, et al. The
epithelial barrier is maintained by
in vivo tight junction expansion during
pathologic intestinal epithelial shedding.
Gastroenterology. 2011;140:1208.
e2-1218.e2. DOI: 10.1053/j.
gastro.2011.01.004
[123]Wang BH, Lai Yeap F, Polya GM.
Differential inhibition of eukaryote
protein kinases by condensed tannins.
Phytochemistry. 1996;43:359-365. DOI:
10.1016/0031-9422(96)00259-2
[124] Contreras TC, Ricciardi E,
Cremonini E, Oteiza PI. ()-
Epicatechin in the prevention of tumor
necrosis alpha-induced loss of Caco-2
cell barrier integrity. Archives of
Biochemistry and Biophysics. 2015;573:
84-91. DOI: 10.1016/j.abb.2015.01.024
[125]Delehanty JB, Johnson BJ,
Hickey TE, Pons T, Ligler FS. Binding
and neutralization of
lipopolysaccharides by plant
proanthocyanidins. Journal of Natural
Products. 2007;70:1718-1724. DOI:
10.1021/np0703601
[126]Williams AR, Klaver EJ, Laan LC,
Ramsay A, Fryganas C, Difborg R, et al.
Co-operative suppression of
inflammatory responses in human
dendritic cells by plant
proanthocyanidins and products from
the parasitic nematode Trichuris suis.
Immunology. 2017;150:312-328. DOI:
10.1111/imm.12687
[127] Zmora N, Suez J, Elinav E. You
are what you eat: Diet, health and the
gut microbiota. Nature Reviews.
Gastroenterology & Hepatology. 2019;
16:35-56
[128] Guirro M, Costa A, Gual-Grau A,
Herrero P, Torrell H, Canela N, et al.
Effects from diet-induced gut
microbiota dysbiosis and obesity can be
ameliorated by fecal microbiota
transplantation: A multiomics approach.
PLoS One. 2019;14:e0218143. DOI:
10.1371/journal.pone.0218143
[129]Wan Y, Wang F, Yuan J, Li J,
Jiang D, Zhang J, et al. Effects of dietary
fat on gut microbiota and faecal
metabolites, and their relationship with
cardiometabolic risk factors: A 6-month
randomised controlled-feeding trial.
27
Beneficial Effects of Proanthocyanidins on Intestinal Permeability and Its Relationship…
DOI: http://dx.doi.org/10.5772/intechopen.91212
Gut. 2019;68:1417-1429. DOI: 10.1136/
gutjnl-2018-317609
[130] Segata N. Gut microbiome:
Westernization and the disappearance
of intestinal diversity. Current Biology.
2015;25:R611-R613
[131] Buttó LF, Haller D. Dysbiosis in
intestinal inflammation: Cause or
consequence. International Journal of
Medical Microbiology. 2016;306:
302-309
[132] Ley RE, Bäckhed F, Turnbaugh P,
Lozupone CA, Knight RD, Gordon JI.
Obesity alters gut microbial ecology.
Proceedings of the National Academy of
Sciences of the United States of
America. 2005;102:11070-11075. DOI:
10.1073/pnas.0504978102
[133] Lee SM, Kim N, Yoon H, Nam RH,
Lee DH. Microbial changes and host
response in F344 rat colon depending on
sex and age following a high-fat diet.
Frontiers in Microbiology. 2018;9:2236.
DOI: 10.3389/fmicb.2018.02236
[134] Ley RRE, Turnbaugh PJP, Klein S,
Gordon JIJ. Microbial ecology: Human
gut microbes associated with obesity.
Nature. 2006;444:1022-1023. DOI:
10.1038/4441022a
[135] Koliada A, Syzenko G, Moseiko V,
Budovska L, Puchkov K, Perederiy V,
et al. Association between body mass
index and Firmicutes/Bacteroidetes ratio
in an adult Ukrainian population. BMC
Microbiology. 2017;17:120. DOI:
10.1186/s12866-017-1027-1
[136]Duncan SH, Lobley GE, Holtrop G,
Ince J, Johnstone AM, Louis P, et al.
Human colonic microbiota associated
with diet, obesity and weight loss.
International Journal of Obesity. 2008;
32:1720-1724. DOI: 10.1038/ijo.2008.155
[137] Schwiertz A, Taras D, Schäfer K,
Beijer S, Bos NA, Donus C, et al.
Microbiota and SCFA in lean and
overweight healthy subjects. Obesity.
2010;18:190-195. DOI: 10.1038/
oby.2009.167
[138] Castaner O, Goday A, Park YM,
Lee SH, Magkos F, Shiow SATE, et al.
The gut microbiome profile in obesity: A
systematic review. International Journal
of Endocrinology. 2018;2018:1-9. DOI:
10.1155/2018/4095789
[139]Garrett WS, Lord GM, Punit S,
Lugo-Villarino G, Mazmanian SKK,
Ito S, et al. Communicable ulcerative
colitis induced by T-bet deficiency in
the innate immune system. Cell. 2007;
131:33-45. DOI: 10.1016/j.
cell.2007.08.017
[140] Karczewski J, Poniedziałek B,
Adamski Z, Rzymski P. The effects of
the microbiota on the host immune
system. Autoimmunity. 2014;47:
494-504
[141] Etxeberria U, Fernández-Quintela
A, Milagro FI, Aguirre L, Martínez JA,
Portillo MP. Impact of polyphenols and
polyphenol-rich dietary sources on gut
microbiota composition. Journal of
Agricultural and Food Chemistry. 2013;
61:9517-9533. DOI: 10.1021/jf402506c
[142] Tzounis X, Rodriguez-Mateos A,
Vulevic J, Gibson GR, Kwik-Uribe C,
Spencer JPE. Prebiotic evaluation of
cocoa-derived flavanols in healthy
humans by using a randomized,
controlled, double-blind, crossover
intervention study. The American
Journal of Clinical Nutrition. 2011;93:
62-72. DOI: 10.3945/ajcn.110.000075.
Diet.
[143]Queipo-Ortuño MI, Boto-
Ordóñez M, Murri M, Gomez-
Zumaquero JM, Clemente-Postigo M,
Estruch R, et al. Influence of red wine
polyphenols and ethanol on the gut
microbiota ecology and biochemical
biomarkers. The American Journal of
Clinical Nutrition. 2012;95:1323-1334.
DOI: 10.3945/ajcn.111.027847
28
Weight Management
[144]Hervert-Hernández D, Goñi I.
Dietary polyphenols and human gut
microbiota: A review. Food Review
International. 2011;27:154-169. DOI:
10.1080/87559129.2010.535233
[145] Cardona F, Andrés-Lacueva C,
Tulipani S, Tinahones FJ, Queipo-
Ortuño MI. Benefits of polyphenols on
gut microbiota and implications in
human health. The Journal of Nutritional
Biochemistry. 2013;24:1415-1422. DOI:
10.1016/j.jnutbio.2013.05.001
[146] Cueva C, Sánchez-Patán F,
Monagas M, Walton GE, Gibson GR,
Martín-Álvarez PJ, et al. In vitro
fermentation of grape seed flavan-3-ol
fractions by human faecal microbiota:
Changes in microbial groups and
phenolic metabolites. FEMS
Microbiology Ecology. 2013;83:792-805.
DOI: 10.1111/1574-6941.12037
[147] Anhê FF, Pilon G, Roy D,
Desjardins Y, Levy E, Marette A.
Triggering Akkermansia with dietary
polyphenols: A new weapon to combat
the metabolic syndrome? Gut Microbes.
2016;7:146-153. DOI: 10.1080/
19490976.2016.1142036
[148] Xing Y-W, Lei G-T, Wu Q-H,
Jiang Y, Huang M-X. Procyanidin B2
protects against diet-induced obesity
and non-alcoholic fatty liver disease via
the modulation of the gut microbiota in
rabbits. World Journal of
Gastroenterology. 2019;25:955-966.
DOI: 10.3748/wjg.v25.i8.955
[149] Tao W, Zhang Y, Shen X, Cao Y,
Shi J, Ye X, et al. Rethinking the
mechanism of the health benefits of
proanthocyanidins: Absorption,
metabolism, and interaction with gut
microbiota. Comprehensive Reviews in
Food Science and Food Safety. 2019;18:
971-985. DOI: 10.1111/1541-4337.12444
[150] Casanova-Martí À, Serrano J,
Portune KJ, Sanz Y, Blay MT, Terra X,
et al. Grape seed proanthocyanidins
influence gut microbiota and
enteroendocrine secretions in female
rats. Food & Function. 2018;9:
1672-1682. DOI: 10.1039/c7fo02028g
[151] Everard A, Belzer C, Geurts L,
Ouwerkerk JP, Druart C, Bindels LB,
et al. Cross-talk between Akkermansia
muciniphila and intestinal epithelium
controls diet-induced obesity.
Proceedings of the National Academy of
Sciences of the United States of
America. 2013;110:9066-9071. DOI:
10.1073/pnas.1219451110
[152]Gotteland M, Andrews M,
Toledo M, Muñoz L, Caceres P,
Anziani A, et al. Modulation of
Helicobacter pylori colonization with
cranberry juice and Lactobacillus
johnsonii La1 in children. Nutrition.
2008;24:421-426. DOI: 10.1016/j.
nut.2008.01.007
[153] Pastene E, Parada V, Avello M,
Ruiz A, García A. Catechin-based
procyanidins from Peumus boldusMol.
aqueous extract inhibit Helicobacter
pylori urease and adherence to
adenocarcinoma gastric cells.
Phytotherapy Research. 2014;28:
1637-1645. DOI: 10.1002/ptr.5176
[154]Mena P, Bresciani L, Brindani N,
Ludwig IA, Pereira-Caro G, Angelino D,
et al. Phenyl-γ-valerolactones and
phenylvaleric acids, the main colonic
metabolites of flavan-3-ols: Synthesis,
analysis, bioavailability, and bioactivity.
Natural Product Reports. 2019;36:
714-752
29
Beneficial Effects of Proanthocyanidins on Intestinal Permeability and Its Relationship…
DOI: http://dx.doi.org/10.5772/intechopen.91212
